[Edaily Starin Choi Hee-jae Reporter] The movie "The Intern," starring Choi Min-sik and Han So-hee, has held the No. 1 spot at the box office for six consecutive days, edging out "The Odyssey." Ahead of the Chuseok holiday, competition for advance ticket sales is heating up with the release of new films such as "The Assassin(s)." Poster for the movie “The Intern” (Photo courtesy of Warner Bros. Korea) According to the Korean Film Council’s integrated computer network on the 22nd, “The Intern” drew 33,849 viewers on the 21st, bringing its cumulative audience count to 437,744. Released on the 16th, “The Intern” has maintained its box office momentum by holding the top spot for six consecutive days since its release. “The Martian,” which ranked second during the same period, drew 32,938 viewers. Its cumulative attendance stands at 11,250,551. In third place was the horror film “Obsession,” which drew 19,569 viewers, bringing its cumulative total to 721,278. “Resident Evil: Night Zero,” in fourth place, drew 11,035 viewers, while “Assassins,” in fifth place, drew 4,274. “Assassins” is set to open on the 23rd. Ahead of the Chuseok holiday box office rush, “Assassins” outpaced “The Odyssey” in advance ticket sales. As of 8:08 a.m. on the 22nd, “Assassins” had sold 185,022 tickets, ranking first in advance ticket sales. “The Odyssey” ranked second with 124,937 tickets sold. Next, *Tazza: The Song of Beelzebub*, which opens on the 23rd, took third place with 95,035 tickets, while *The Intern* ranked fourth with 50,535 tickets. The re-release of *Avengers: Endgame Encore* came in fifth with 41,595 tickets. With new Korean films such as “The Assassin(s)” and “Tazza: The Song of Beelzebub” hitting theaters following “The Intern,” which has held the top spot at the box office since its release, attention is focused on the box office battle during the Chuseok holiday.
Image of SamsungElectronics’ “Bespoke AI Family Hub” refrigerator. (Photo courtesy of SamsungElectronics)
SamsungElectronics’ “Bespoke AI Family Hub” refrigerator and “Moving Style” portable scree…
GENINUS Inc.(389030)is embarking on experimental research to verify the feasibility of developing actual treatments based on new anti-cancer drug targets identified using artificial intelligence (AI).…
#Onconic Therapeutics Inc. has unveiled a new drug candidate designed to reduce muscle loss that can occur during weight loss when used in combination with existing glucagon-like peptide-1 (GLP-1) cla…